๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Short-term outcomes of living-related liver transplantation for primary biliary cirrhosis and its recurrence: report of five cases

โœ Scribed by T Takeishi; Y Sato; T Ichida; S Yamamoto; T Kobayashi; K Hatakeyama

Book ID
117232955
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
42 KB
Volume
35
Category
Article
ISSN
0041-1345

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Long-term survival and impact of ursodeo
Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation
โœ Phunchai Charatcharoenwitthaya; Sylvania Pimentel; Jayant A. Talwalkar; Felicity ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 275 KB ๐Ÿ‘ 2 views

The recurrence of primary biliary cirrhosis (PBC) in the hepatic allograft may impact patient and graft survival with long-term follow-up. The efficacy of ursodeoxycholic acid (UDCA) for treatment of recurrent PBC after liver transplantation (LT) remains less well known. The aims of this study were

Impact of human leukocyte antigen mismat
Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis
โœ Daisuke Morioka; Hiroto Egawa; Mureo Kasahara; Tomoyasu Jo; Seisuke Sakamoto; Ya ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 140 KB ๐Ÿ‘ 1 views

Patient selection criteria of deceased donor liver transplantation for primary biliary cirrhosis (PBC) are almost completely established. The aim of this study was to establish selection criteria for both patients and donors of living donor liver transplantation (LDLT) for PBC. We used univariate an

Impact of human leukocyte antigen mismat
Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis
โœ Takuya Hashimoto; Yasuhiko Sugawara; Masatoshi Makuuchi ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 74 KB ๐Ÿ‘ 1 views

We read with great interest the recent article from the Kyoto group regarding primary biliary cirrhosis (PBC) patients after living donor liver transplantation (LDLT). 1 Of 50 patients, 14 died within 6 months after LDLT, and 9 patients showed recurrence with a median follow-up duration of 36 months